During the past decade, University Pointe conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 23 clinical trials were completed, i.e. on average, 143.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Pointe" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Pointe" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "University Pointe" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Estrogen Receptor Negative" (2 trials). Many other conditions were trialed in "University Pointe" in a lesser frequency.

Most popular intervention types in "University Pointe" are "Drug" (36 trials), "Other" (19 trials), "Biological" (13 trials), "Radiation" (11 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials), "Docetaxel" (4 trials) and "Durvalumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "University Pointe" are 40 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University Pointe". undefined are not yet recruiting, 7 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University Pointe, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Pointe, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".